Document is current
Any future updates will be listed below
-
Authors
Kahya, Melike
Gouskova, Natalia A.
Lo, On-Yee
Zhou, Junhong
Cappon, Davide
Finnerty, Emma
Pascual-Leone, Alvaro
Lipsitz, Lewis A.
Hausdorff, Jeffrey M.
Manor, Brad
-
Funding
Funding for this research was provided by:
National Institute on Aging (T32AG023480, R21 AG064575)
Family of Beth and Richard Marcus Research Fund
National Institutes of Health (R24AG06142)
Neuroelectrics Corp.
U.S.-Israel Binational Science Foundation (2015271)
Boston Claude D. Pepper Older Americans Independence Center (P30-AG013679)
- License Information
-
More Information
Article History
Received: 19 July 2022
Accepted: 25 October 2022
First Online: 11 November 2022
Declarations
:
: This study was approved by the Institutional Review Board of Hebrew SeniorLife and conducted in accordance with the principles of the Declaration of Helsinki. All participants provided written informed consent at the beginning of their first study visit.
: Written informed consent was obtained for data collection, analysis, and publication from all study participants.
: Dr. A. Pascual-Leone serves as a paid member of the scientific advisory boards for Neuroelectrics, Magstim Inc., TetraNeuron, Skin2Neuron, MedRhythms, and Hearts Radiant. He is co-founder of TI solutions and co-founder and chief medical officer of Linus Health. None of these companies have any interest in or have contributed to the present work.Dr. A Pascual-Leone is listed as an inventor on several issued and pending patents on the real-time integration of transcranial magnetic stimulation with electroencephalography and magnetic resonance imaging, and applications of noninvasive brain stimulation in various neurological disorders.
